GastroIntestinal Biosciences — Los Angeles, California

GastroIntestinal Biosciences is a clinical research site located in Los Angeles, California, United States 90067-2015.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

GastroIntestinal Biosciences has participated in 3 clinical trials.

Therapeutic areas: Liver Fibrosis, Nonalcoholic Fatty Liver Disease (NAFLD), Nonalcoholic Steatohepatitis.

Sponsors: Bristol-Myers Squibb, Tobira Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GastroIntestinal Biosciences?

GastroIntestinal Biosciences has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GastroIntestinal Biosciences conducted?

GastroIntestinal Biosciences has 3 clinical trials on record. Their work covers Liver Fibrosis, Nonalcoholic Fatty Liver Disease (NAFLD), Nonalcoholic Steatohepatitis.

Is GastroIntestinal Biosciences accredited by Crixeo Health?

GastroIntestinal Biosciences has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GastroIntestinal Biosciences?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.